Lipid Disorders
From the Journals
Daily polypill lowers BP, cholesterol in underserved population
The regimen’s simplicity and low cost may overcome barriers to treatment, such as lack of income, underinsurance, and difficulty attending clinic...
Conference Coverage
European cholesterol guidelines push LDL targets below 55 mg/dL
PARIS –
Conference Coverage
Statins may do double duty as antidepressants
COPENHAGEN – Mounting evidence suggests antidepressant efficacy for statins in immunometabolic-related depression.
Video
Survival at ‘overweight’ BMI surpasses ‘normal’
PARIS – Data from more than 142,000 middle-aged people worldwide show those with a body mass index of 25-29 kg/m2 outlast those at 20-...
Conference Coverage
siRNA drug safely halved LDL cholesterol in phase 3 ORION-11
PARIS –
News
In PAD, dropping statins ups death risk 43%
PARIS – Statin adherence saves lives in peripheral arterial disease.
From the Journals
PCSK9 inhibition cuts events in very-high-risk groups
ODYSSEY OUTCOMES analyses peg prior CABG and polyvascular disease as targets for alirocumab.
Latest News
Evinacumab shows promise for HoFH in top line results
Reductions of LDL cholesterol were seen at 2 weeks and were maintained for the rest of the 24-week study period.
From the Journals
Older patients who stop statins may be increasing their cardiovascular risk
Discontinuation of statins was associated with an increased risk of hospital admission for a cardiovascular event.
From the Journals
Plant-based foods could keep type 2 diabetes at bay
Meta-analysis suggests diets high in nonanimal foods may significantly lower risk.
Latest News
BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adults
SAN FRANCISCO – One risk factor should trigger screening in normal weight.